Literature DB >> 512881

Physical model evaluation of topical prodrug delivery-simultaneous transport and bioconversion of vidarabine-5'-valerate II: Parameter determinations.

C D Yu, J L Fox, N F Ho, W I Higuchi.   

Abstract

Results of initial studies on methods for determining various model parameters are reported. By employing excised hairless mouse skin in a diffusion cell system, numerous model parameter values were deduced. The stratum corneum permeability was estimated from steadystate fluxes with preparations of heat-separated epidermal membranes. Determinations of dermis diffusivities and enzyme rate constants in situ involved considering the simultaneous transport and the enzyme processes and factoring the diffusivities and enzyme rate constants from the overall kinetics. Dermal diffusivities were on the order of 10-6 cm2/sec for vidarabine and its 5'-valerate ester. The enzyme rate constants were 1.70 x 10-3 sec-1 for the esterase and 8.68 x 10-3 sec-1 for the deaminase.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 512881     DOI: 10.1002/jps.2600681105

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Dose-dependent enhancement effects of azone on skin permeability.

Authors:  W J Lambert; W I Higuchi; K Knutson; S L Krill
Journal:  Pharm Res       Date:  1989-09       Impact factor: 4.200

2.  Quantitative evaluation of ethanol effects on diffusion and metabolism of beta-estradiol in hairless mouse skin.

Authors:  P Liu; W I Higuchi; W Q Song; T Kurihara-Bergstrom; W R Good
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

3.  Skin structure and metabolism: relevance to the design of cutaneous therapeutics.

Authors:  D A Bucks
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

4.  Proteolysis of human calcitonin in excised bovine nasal mucosa: elucidation of the metabolic pathway by liquid secondary ionization mass spectrometry (LSIMS) and matrix assisted laser desorption ionization mass spectrometry (MALDI).

Authors:  S R Lang; W Staudenmann; P James; H J Manz; R Kessler; B Galli; H P Moser; A Rummelt; H P Merkle
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

5.  Percutaneous absorption of benzoic acid across human skin. I. In vitro experiments and mathematical modeling.

Authors:  G E Parry; A L Bunge; G D Silcox; L K Pershing; D W Pershing
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

6.  Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs.

Authors:  W M Shannon; G Arnett; D C Baker; S D Kumar; W I Higuchi
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

7.  Physicochemical interpretation of the pharmacokinetics of percutaneous absorption.

Authors:  R H Guy; J Hadgraft
Journal:  J Pharmacokinet Biopharm       Date:  1983-04

8.  In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum.

Authors:  F Yamashita; H Bando; Y Koyama; S Kitagawa; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

9.  Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone.

Authors:  Haranath K Vaddi; Stan L Banks; Jianhong Chen; Dana C Hammell; Peter A Crooks; Audra L Stinchcomb
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

10.  In vivo evaluation of a transdermal codrug of 6-beta-naltrexol linked to hydroxybupropion in hairless guinea pigs.

Authors:  Paul K Kiptoo; Kalpana S Paudel; Dana C Hammell; Mohamed O Hamad; Peter A Crooks; Audra L Stinchcomb
Journal:  Eur J Pharm Sci       Date:  2008-01-31       Impact factor: 4.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.